SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-16-131725
Filing Date
2016-11-04
Accepted
2016-11-04 16:02:48
Documents
1
Group Members
FRED KNOLLGAKASA HOLDINGS, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v452245_sc13g.htm SC 13G 93264
  Complete submission text file 0001144204-16-131725.txt   95151
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Subject) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-33655 | Film No.: 161975173
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017
Business Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017 212-808-7474
Knoll Capital Management, LP (Filed by) CIK: 0001325083 (see all company filings)

IRS No.: 133476926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G